Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Is Safe and Effective: 5-Year Outcomes of a Phase II Trial
BJU International - United Kingdom
doi 10.1111/bju.14925
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 8, 2019
Authors
Publisher
Wiley